Seed Round Open

The Future of
Preventive Healthcare

Invest in the platform democratizing elite medicine. Proprietary AI engine, zero-CAC B2B2C distribution, and defensible technology moats.

Regain is building the operating system for personalized preventive healthcare, transforming how 150 million Americans with chronic conditions access elite-level medical care.

$450B+
TAM
$5M
Seed Round
10:1+
LTV:CAC Target
150M
US Chronic Patients
Proprietary Popperian AI reasoning engine
Zero-CAC patient acquisition via lab partnerships
Multiple revenue streams: subscriptions + marketplace
Market Opportunity

A $450B+ Opportunity

The convergence of three massive markets creates unprecedented opportunity

$450B+
Total Addressable Market
TAM
US Chronic Disease $350B
Digital Health $350B
Longevity/Wellness $100B
$85B
Serviceable Market
SAM
Chronic Patients 133M
Health Optimizers 45M
Annual Spending $85B
$8.5B
5-Year Target
SOM
Disease Reversal $4B
Optimization Subs $2.5B
Marketplace GMV $2B
8%
Chronic Disease CAGR
15%
Digital Health CAGR
12%
Longevity Market CAGR
Defensibility

Competitive Moats

Five layers of sustainable competitive advantage

1

Proprietary Popperian AI Engine

Unlike probabilistic symptom checkers that guess diagnoses, our Assessment Engine uses Critical Rationalism. It generates hypotheses, then systematically attempts to refute them using the user's Health State data.

Multi-agent adversarial debate Schema-driven guardrails Closed-loop learning
2

Unified Health State Data Network Effect

Every user interaction enriches a versioned, longitudinal Health State spanning four dimensions: subjective (symptoms), objective (wearables), clinical (labs), and contextual (lifestyle).

Increasing accuracy Cross-condition insights Compounding switching costs
3

Zero-CAC B2B2C Distribution via Labs

Our Labs Module transforms static lab results into dynamic engagement funnels. Partner laboratories send results through our platform, patients download the app to access enhanced AI reports.

Partners pay nothing High health intent Instant conversion
4

Clinical Services Layer Optionality

Our regulatory architecture enables seamless toggling between D2C wellness (no physician) and full clinical mode (physician-in-the-loop). Capture value across the entire care spectrum.

No FDA device classification Flexible positioning
5

Mini-App Factory Platform Effect

Generative UI architecture enables rapid deployment of condition-specific 'Editions' (Metabolic Reset, Longevity Protocol, Heart Health) without new code. Each successful Edition attracts condition-specific populations.

Rapid deployment Network effects
Architecture

Technology Stack

Six integrated layers powering personalized preventive healthcare

The Spine
Health State Engine
Unified patient data across all touchpoints
The Brain
Popperian Assessment Engine
Explanation-driven AI reasoning
Deep dive: Epistemological Foundations →
The Muscle
Protocol Engine
KPI-based lifestyle interventions
The Shield
Safety/Escalation System
Red-flag detection, compliance guardrails
The Clinic
Clinical Services Layer
Physician-in-the-loop telemedicine
The Factory
Generative UI
Rapid condition-specific app generation

Compliance as a Technical Moat

Coercion-resistant architecture that turns HIPAA/GDPR compliance from a checklist into a structural asset.

Cryptographic Isolation
PII and PHI in separate environments using non-exportable Transit keys in HSM-backed Vaults
No All-Powerful Admin
Structurally eliminated single points of compromise at the architecture level
Shamir's Secret Sharing
All administrative actions gated by multi-party quorum approval
SHA-256 Hash Chaining
All actions recorded in immutable ledger—tampering is mathematically detectable
Fail-Closed System — Protects company valuation from data breaches, insider threats, and legal overreach through definitive Data Residency and regulatory alignment.
01
Hard-to-Vary Scoring
Every recommendation scored on interdependence, specificity, parsimony, and falsifiability
Learn more →
02
Evidence Engine
Curated scientific archive with full citation binding to peer-reviewed sources
03
Collaborative Intelligence
Glass Box reasoning trace for physicians with override capabilities
04
Offline-First Mobile
WatermelonDB-powered local sync for emerging market expansion
Economics

Business Model

Multiple revenue streams with compelling unit economics

$29-149
/month
Subscriptions
B2C monthly/annual plans
80%+ gross margin
$299-999
/program
Programs
6-week condition-specific programs
One-time fee
10%
take rate
LifeSense Marketplace
Platform fee on GMV
$2B+ GMV opportunity
$75-150
/visit
Clinical Services
Physician consultations
Partner revenue share
SaaS + Rev Share
licensing model
Enterprise/B2B2C
Lab partner integrations, white-label solutions, health system contracts
Recurring + usage-based revenue

Unit Economics Target

~$0
CAC via Labs funnel
$1,200+
LTV (24-month)
10:1+
LTV:CAC at scale
<3mo
Payback period

The Labs Flywheel

1
Lab sends results
2
Patient downloads
$0 CAC
3
AI report + plan
4
Retest in 90 days
4× volume
Roadmap

Growth Strategy

A clear path from seed to scale

Phase 1

Foundation

Months 0-12
  • Launch Metabolic Reset flagship program
  • Secure 5-10 regional lab partnerships
  • 10,000 active users
  • Prove unit economics
Phase 2

Expansion

Months 12-24
  • Launch 5+ condition-specific Editions
  • Expand to national lab networks
  • Build BYOD physician network
  • International expansion (HL7/FHIR)
Phase 3

Platform

Months 24-36
  • LifeSense marketplace $500M+ GMV
  • Enterprise health system deals
  • White-label international licensing
  • Payer contracts via outcomes data

Key Milestones

Timeline
Milestone
Q1 2025
Beta launch with 3 lab partners
Q2 2025
5,000 active users, first revenue
Q4 2025
25,000 users, positive unit economics proven
Q2 2026
100,000 users, Series A metrics
Q4 2026
National lab partnerships, $10M ARR run rate
Investment Ask

$5M Seed Round

Achieve product-market fit and prove unit economics at scale

Use of Funds

Engineering 45%
Clinical Operations 20%
Lab Partnerships & BD 20%
Marketing & Growth 10%
G&A 5%

Milestones This Round Enables

25K+
Active Users
Validated product-market fit
10+
Lab Partnerships
National distribution footprint
5:1+
LTV:CAC Demonstrated
Proven unit economics
10×
Series A Path
$25-50M at 10×+ valuation

Healthcare is ripe for disruption. Join us in building the future.

Seeking Strategic Partners

Let's Build Together

Contact me directly. I'd love to share our vision and discuss opportunities.

$450B+ TAM
10:1+ LTV:CAC Target
150M US Patients
Anton Kim

Anton Kim

CEO, Regain Inc.

This document contains forward-looking statements. Investment involves risk. Past performance does not guarantee future results.